163 related articles for article (PubMed ID: 16323420)
1. Suppression of autoimmunity via microbial mimics of altered peptide ligands.
Steinman L; Utz PJ; Robinson WH
Curr Top Microbiol Immunol; 2005; 296():55-63. PubMed ID: 16323420
[TBL] [Abstract][Full Text] [Related]
2. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy.
Steinman L
J Exp Med; 1999 Apr; 189(7):1021-4. PubMed ID: 10190892
[No Abstract] [Full Text] [Related]
3. Experimental autoimmune encephalomyelitis.
Rao P; Segal BM
Methods Mol Med; 2004; 102():363-75. PubMed ID: 15286395
[TBL] [Abstract][Full Text] [Related]
4. A virus-induced molecular mimicry model of multiple sclerosis.
Olson JK; Ercolini AM; Miller SD
Curr Top Microbiol Immunol; 2005; 296():39-53. PubMed ID: 16323419
[TBL] [Abstract][Full Text] [Related]
5. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
Greer JM; Pender MP
J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor.
Greene MT; Ercolini AM; DeGutes M; Miller SD
J Autoimmun; 2008 Dec; 31(4):399-407. PubMed ID: 19008075
[TBL] [Abstract][Full Text] [Related]
7. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
Croxford JL; Anger HA; Miller SD
J Immunol; 2005 Jan; 174(2):907-17. PubMed ID: 15634913
[TBL] [Abstract][Full Text] [Related]
8. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
9. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide.
Pedotti R; Mitchell D; Wedemeyer J; Karpuj M; Chabas D; Hattab EM; Tsai M; Galli SJ; Steinman L
Nat Immunol; 2001 Mar; 2(3):216-22. PubMed ID: 11224520
[TBL] [Abstract][Full Text] [Related]
10. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
[TBL] [Abstract][Full Text] [Related]
11. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1.
Aharoni R; Teitelbaum D; Sela M; Arnon R
J Neuroimmunol; 1998 Nov; 91(1-2):135-46. PubMed ID: 9846830
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry revisited: gut bacteria and multiple sclerosis.
Westall FC
J Clin Microbiol; 2006 Jun; 44(6):2099-104. PubMed ID: 16757604
[TBL] [Abstract][Full Text] [Related]
13. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Recks MS; Grether NB; van der Broeck F; Ganscher A; Wagner N; Henke E; Ergün S; Schroeter M; Kuerten S
Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice.
Massilamany C; Thulasingam S; Steffen D; Reddy J
J Neuroimmunol; 2011 Jan; 230(1-2):95-104. PubMed ID: 20950867
[TBL] [Abstract][Full Text] [Related]
15. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice.
Massilamany C; Asojo OA; Gangaplara A; Steffen D; Reddy J
Int Immunol; 2011 Dec; 23(12):729-39. PubMed ID: 22058327
[TBL] [Abstract][Full Text] [Related]
16. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis.
Ruiz PJ; Garren H; Hirschberg DL; Langer-Gould AM; Levite M; Karpuj MV; Southwood S; Sette A; Conlon P; Steinman L
J Exp Med; 1999 Apr; 189(8):1275-84. PubMed ID: 10209044
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus.
Croxford JL; Ercolini AM; Degutes M; Miller SD
Eur J Immunol; 2006 Oct; 36(10):2671-80. PubMed ID: 16981179
[TBL] [Abstract][Full Text] [Related]
18. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
19. Turning over the Chance card on MS susceptibility.
Ransohoff RM
Nat Immunol; 2010 Jul; 11(7):570-2. PubMed ID: 20562841
[No Abstract] [Full Text] [Related]
20. Candidate autoantigens in multiple sclerosis.
Schmidt S
Mult Scler; 1999 Jun; 5(3):147-60. PubMed ID: 10408714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
